S1F, G)
Islam R, Bilal H, Wang X, Zhang L
10.1016/S2213-2600(25)00019-0 Summary Keywords dipeptidyl peptidase 1 inhibitors, neutrophil serine proteases, non-cystic fibrosis bronchiectasis, chronic obstructive pulmonary disease, brensocatib, BI 1291583, HSK31858, clinical trials Citation Zhang D, Zhang W, Hu P and Zhang W (2025) Dipeptidyl peptidase 1 inhibitors for inflammatory respiratory diseases: mechanisms, clinical trials, and therapeutic prospects
This included an assessment of trial comparability and generation of outcome-specific networks
The calculator will estimate the matching mL amount and U-100 syringe units
Nanoparticles therapeutic strategies for the treatment human diseases The above-mentioned small molecule ferroptosis regulators have demonstrated potential in preclinical practice for treating various diseases